Anaphylaxis
Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.
Leaflet NEISVAC-C 0.5ml suspension for injection in pre-filled syringe
- Product code:
- W64735003
- Quantity:
- 20
- Indicated for:
- prevention of meningococcal disease
- Route of administration:
- injectable
- Substance:
- group C meningococcal polysaccharide vaccine (vaccine)
- ATC
- J07AH07 — Antiinfectives for systemic use | Bacterial vaccines | Meningococcal vaccines
Precautions:
Additional monitoring
This medicine is subject to additional monitoring.
Refrigerated storage
Store in the refrigerator as instructed in the leaflet.
Protect from light
Store protected from light.
The group C meningococcal polysaccharide vaccine is used to prevent infections caused by Neisseria meningitidis serogroup C, a bacterium that can cause meningitis and septicemia. The vaccine contains purified capsular polysaccharides from serogroup C, which stimulate the immune system to produce specific antibodies against this serogroup.
The vaccine is administered subcutaneously or intramuscularly, usually in a single dose, and is recommended for individuals at increased risk of infection, such as those living in crowded communities or traveling to endemic areas.
Common side effects include pain at the injection site, mild fever, and fatigue. In rare cases, severe allergic reactions may occur.
The group C meningococcal polysaccharide vaccine is an important preventive measure for reducing the incidence of meningococcal diseases caused by serogroup C, helping to protect vulnerable populations and prevent outbreaks.
The vaccine is administered subcutaneously or intramuscularly, usually in a single dose, and is recommended for individuals at increased risk of infection, such as those living in crowded communities or traveling to endemic areas.
Common side effects include pain at the injection site, mild fever, and fatigue. In rare cases, severe allergic reactions may occur.
The group C meningococcal polysaccharide vaccine is an important preventive measure for reducing the incidence of meningococcal diseases caused by serogroup C, helping to protect vulnerable populations and prevent outbreaks.
General data about NEISVAC-C 0.5ml
- Substance:
- group C meningococcal polysaccharide vaccine
- Date of latest medicines list:
- 01-12-2018
- Product code:
- W64735003
- Concentration:
- 0.5ml
- Pharmaceutical form:
- suspension for injection in pre-filled syringe
- Quantity:
- 20
- Product type:
- Original
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.